Sarcomas are a diverse group of cancers that originate from connective tissues, such as bones, muscles, and nerves. They account for a relatively small percentage of all cancer cases, making them a rare entity in the world of oncology. However, within this already uncommon group of malignancies, there exist even rarer subtypes that pose unique challenges for patients and physicians alike. In this article, we delve into the characteristics of these rare sarcoma subtypes, shedding light on their aggressive nature and the need for specialised treatment approaches.
In an interaction with OnlyMyHealth, Dr Nikhil Mehta Consultant Surgical Oncologist, HCG Cancer Centre, Jaipur, explained about the characteristics of rare sarcoma.
Alveolar Soft Part Sarcoma
The term "rare sarcoma subtypes" encompasses a wide array of malignancies, each with its own distinct features. One such subtype is alveolar soft part sarcoma (ASPS), a highly aggressive tumour that typically affects young adults. ASPS often presents as a painless mass in the extremities, lungs, or other soft tissues.
Despite its slow growth pattern, it has a propensity for metastasis, frequently spreading to distant sites such as the lungs, bones, or brain. The rarity of ASPS poses a challenge in terms of diagnosis and treatment, as its unique histological characteristics can mimic other tumours, leading to delays in appropriate management.
According to Journal of Oncology Navigation and Survivorship, another rare sarcoma subtype is epithelioid sarcoma, which typically affects young adults in their 20s or 30s. This aggressive malignancy often arises in the extremities, presenting as a painless nodule or ulcer. Epithelioid sarcoma has a remarkable ability to invade surrounding tissues and lymph nodes, making it challenging to achieve complete surgical resection. Furthermore, it tends to recur locally and metastasis to distant sites, particularly the lungs.
Clear cell sarcoma
It is yet another rare subtype characterised by its propensity for recurrence and distant metastasis. This sarcoma usually occurs in young adults, primarily affecting the extremities, with the feet being a common location. Clear cell sarcoma is notorious for its resistance to conventional chemotherapy and radiation therapy, emphasising the need for alternative treatment strategies. Identifying specific molecular alterations, such as the EWSR1-ATF1 gene fusion, has opened doors for targeted therapies that hold promise for improved outcomes in these patients.
Also read: HPV Vaccine: Easiest Way To Get Your Vaccine Against Cervical Cancer In India
Gastrointestinal stromal tumours (GISTs)
It also falls under the umbrella of rare sarcoma subtypes. Although GISTs are relatively more common than the previously mentioned subtypes, comprising 1-3% of all gastrointestinal malignancies, they still represent a rarity in clinical practice.
GISTs typically arise in the stomach or small intestine and may present with abdominal pain, gastrointestinal bleeding, or a palpable mass. Understanding the molecular underpinnings of GISTs has revolutionised their treatment, with the introduction of tyrosine kinase inhibitors providing a breakthrough in the management of metastatic or unresectable disease.
Also read: Colon Cancer Can Affect Youngsters Too, Expert Lists Risk Factors And Early Signs
The rarity of these sarcoma subtypes poses significant challenges in terms of research, clinical trials, and the development of targeted therapies. They are characterised by their aggressive behaviour, propensity for metastasis, and resistance to conventional therapies. Their rarity poses challenges in terms of diagnosis, treatment, and research. Advances in molecular profiling have paved the way for targeted therapies, offering hope for improved outcomes in these patients.